StockData
InspireMD, Inc. logo

InspireMD, Inc. (NSPR) income statement

NSPRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3054% below fair value
$0.69+0.04 (+5.48%)

Close on Nov 18, 2026Market cap $31.87MP/E –Yield –

InspireMD, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
18.1%
Operating margin
-494.0%
Net margin
-484.1%
Return on equity, FY2025
-106.9%

Financial strength

Current ratio
3.80
Debt to equity
–
Debt to assets
–
Cash to current liabilities
157.0%

Valuation

P/E ratio
–
Price to sales
2.94
Price to book
1.01
Dividend yield
–

See a number that looks wrong?